Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Weighing Bleeding Risk in Pulmonary Embolism, With Samantha Pettigrew, MD Samantha Pettigrew, MD

Published Date: 28 Oct 2026

At CHEST 2026, Pettigrew reviewed STRATIFY and STORM-PE data, citing bleeding risk with low-dose alteplase and 90-day walk gains with thrombectomy.

AI and Emerging Technologies in COPD Care, With Jean Bourbeau, MD Jean Bourbeau, MD

Published Date: 28 Oct 2026

At CHEST 2026, Jean Bourbeau, MD, said AI may support COPD diagnosis, remote monitoring, and posthospital care, though most tools still need validation.

Tozorakimab Sustains COPD Exacerbation Benefit to 2 Years: Henrik Watz, MD Henrik Watz, MD, PhD

Published Date: 28 Oct 2026

Henrik Watz, MD, discusses 104-week OBERON, TITANIA, and PROSPERO data on tozorakimab in COPD presented at CHEST 2026.

Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD Gabor Kovacs, MD, PhD

Published Date: 28 Oct 2026

Gabor Kovacs, MD, PhD, discusses phase 2a INSIGNIA PH-COPD results for inhaled frespaciguat presented at CHEST 2026.

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

Published Date: 28 Oct 2026

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

Published Date: 28 Oct 2026

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

Published Date: 28 Oct 2026

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

Inside The New AHA/ACC Acute Pulmonary Embolism Categories

Published Date: 28 Oct 2026

Inside The New AHA/ACC Acute Pulmonary Embolism Categories

Calcium Channel Blockers Linked to Lower Blood Pressure Variability Marco Meglio

Published Date: 28 Oct 2026

A target trial emulation pooling ACCORD-BP and SPRINT data found calcium channel blocker regimens reduced blood pressure variability without changing cardiovascular outcomes.

This Week on NeurologyLive® — October 26, 2026 Isabella Ciccone, MPH

Published Date: 28 Oct 2026

Here's some of what is coming soon to NeurologyLive® this week.

Knowledge Hub

Oncology

Smart Chemotherapy Chair Monitoring Infrastructure: Clinical Applications, Safety, and Future Directions

A clinical review of smart monitoring infrastructure for chemotherapy chairs, including safety benefits, implementation risks, guidelines, and future oncology applications.

Oncology

Radioligand Therapy Optimization Using Tumor-Targeted Alpha-Particle Emitters

A clinical review of targeted alpha-particle radioligand therapy, including mechanisms, patient selection, dosimetry, safety, emerging agents, and guideline-based management.

Oncology

Tumor-Free Tissue Reconstruction After Oncologic Surgery

A medical review of tumor-free tissue reconstruction after cancer surgery, covering biological principles, diagnosis, treatment, advances, risks, outcomes, and guideline-based care.

Oncology

Connected Oncology Day-Care Scheduling Systems: A Medical and Operational Review

A clinical review of connected oncology day-care scheduling systems, including workflow integration, safety, emerging technologies, and implementation guidance.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Weighing Bleeding Risk in Pulmonary Embolism, With Samantha Pettigrew, MD Samantha Pettigrew, MD

AI and Emerging Technologies in COPD Care, With Jean Bourbeau, MD Jean Bourbeau, MD

Tozorakimab Sustains COPD Exacerbation Benefit to 2 Years: Henrik Watz, MD Henrik Watz, MD, PhD

Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD Gabor Kovacs, MD, PhD

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

Inside The New AHA/ACC Acute Pulmonary Embolism Categories

Calcium Channel Blockers Linked to Lower Blood Pressure Variability Marco Meglio

This Week on NeurologyLive® — October 26, 2026 Isabella Ciccone, MPH

Knowledge Hub

Smart Chemotherapy Chair Monitoring Infrastructure: Clinical Applications, Safety, and Future Directions

Radioligand Therapy Optimization Using Tumor-Targeted Alpha-Particle Emitters

Tumor-Free Tissue Reconstruction After Oncologic Surgery

Connected Oncology Day-Care Scheduling Systems: A Medical and Operational Review

Engineered Immune Cells for Solid Tumors: Mechanisms, Clinical Evidence, and Emerging Therapeutic Strategies

Resistance Exercise During Cancer Rehabilitation

Tumor Cell Dormancy Sustained by Extracellular Matrix Mechanical Signaling

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Weighing Bleeding Risk in Pulmonary Embolism, With Samantha Pettigrew, MD Samantha Pettigrew, MD

AI and Emerging Technologies in COPD Care, With Jean Bourbeau, MD Jean Bourbeau, MD

Tozorakimab Sustains COPD Exacerbation Benefit to 2 Years: Henrik Watz, MD Henrik Watz, MD, PhD

Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD Gabor Kovacs, MD, PhD

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

Inside The New AHA/ACC Acute Pulmonary Embolism Categories

Calcium Channel Blockers Linked to Lower Blood Pressure Variability Marco Meglio

This Week on NeurologyLive® — October 26, 2026 Isabella Ciccone, MPH

Knowledge Hub

Smart Chemotherapy Chair Monitoring Infrastructure: Clinical Applications, Safety, and Future Directions

Radioligand Therapy Optimization Using Tumor-Targeted Alpha-Particle Emitters

Tumor-Free Tissue Reconstruction After Oncologic Surgery

Connected Oncology Day-Care Scheduling Systems: A Medical and Operational Review

Engineered Immune Cells for Solid Tumors: Mechanisms, Clinical Evidence, and Emerging Therapeutic Strategies

Resistance Exercise During Cancer Rehabilitation

Tumor Cell Dormancy Sustained by Extracellular Matrix Mechanical Signaling

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views